Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

Peoria, IL, Jan 8, 2025 — Veloxity Labs, a bioanalytical contract research organization (CRO) specializing in accelerating ...

Flybridge's investment memo generator turns a pitch deck and other materials into thoughtful analysis.

– The growth in environmental and health concerns over the production and use of bitumen, unsettled crude oil prices, and the rise in the usage of an option for bitumen are anticipated to hinder the ...

Lentiviral Vectors Market is estimated to be valued at US$ 292 million in 2023 and is expected to exhibit a CAGR of 18.5% during the forecast period (2023-2030) Mr. Shah Coherent Market Insights Pvt.

Intelligent Bio Solutions Inc. (NYSE: GBS) recently reported significant adjustments in its outstanding shares following recent transactions. According to a Form 8-K filed with the Securities and ...

In the world of tech startups, unicorns – companies achieving billion-dollar valuations – have long symbolized success. But ...

Immunoassay analyzers are used to identify and detect the concentration of specific substances in a sample, usually using an antibody as a reagent. These devices are used in hospitals and clinical ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Want to grow a six-figure coaching business? With the industry booming, it’s your moment. Here are 5 strategies that worked ...

The future of the trailblazing gene therapy company bluebird bio Inc. — which was once worth nearly as much as the airline ...